Digoxin
NDC 59651-436, Digoxin, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 59651-436
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214982
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-436 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIGOXIN.0625 mg/1
Pharmacologic classes
Cardiac Glycoside [EPC]; Cardiac Glycosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-436-01 | 59651043601 | 100 TABLET in 1 BOTTLE (59651-436-01) |
| 59651-436-99 | 59651043699 | 1000 TABLET in 1 BOTTLE (59651-436-99) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2bcd56ee-4497-4b8d-84db-a1470c77827bNADAC price for package 59651043601
GET /v1/drugs/nadac/59651043601
Use it
Look up 59651-436 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-436 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-436. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.